Learn about the latest study findings from Linus Health

Ali Jannati, MD, PhD
Director of Cognitive Science, Linus Health

Poster #0396

Key takeaways:

A combination of multimodal machine-learning models based on the Digital Clock and Recall (DCR) – the DCR Cognition Score and the Amyloid Positivity Risk showed strong performance for identifying individuals who have mild cognitive impairment or mild dementia likely due to Alzheimer’s disease, and therefore potentially suitable candidates for disease-modifying treatments.

DEMENTIA CARE AND HEALTH SERVICES RESEARCH

Feasibility And User Acceptance Of The Electronic Person-specific Outcome Measure (ePSOM) In Japan

Stina Saunders, PhD
Personalized Medicine Lead, Linus Health

Poster #0752

Key takeaways:

Interim data from the ePSOM feasibility study in Japan show ePSOM can be deployed in a culturally distinct clinical setting without structural adaptation, supporting its use in global AD trials to capture personally meaningful priorities and establish meaningful treatment benefits.

CLINICAL MANIFESTATIONS: NEUROPSYCHOLOGY

The Digital Clock And Recall Outperforms MOCA In Detecting Mild Cognitive Impairment In A Real-world Clinical Setting

Ali Jannati, MD, PhD
Director of Cognitive Science, Linus Health

Poster #0846